Analysis of the androgenic activity of synthetic “progestins” currently used for the treatment of prostate cancer
Authors:
- F. LabrieFLF. Labrie
- 1 October 1987
- journal article
- research article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 28 (4) , 379-384
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Treatment of Prostate Cancer with Gonadotropin-Releasing Hormone AgonistsEndocrine Reviews, 1986
- Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in advanced prostate cancer: A marked improvement in response and survivalJournal of Steroid Biochemistry, 1985
- Comparison of the antiandrogenic/androgenic activities of flutamide, cyproterone acetate and megestrol acetateMolecular and Cellular Endocrinology, 1985
- Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones aloneCancer, 1983
- Cardiovascular Complications in the Treatment of Prostatic CarcinomaBritish Journal of Urology, 1981
- Antifertility Effects of LHRH Agonists in the MaleJournal of Andrology, 1980
- Synandrogenic and Antiandrogenic Effect of Progestins: Comparison with Nonprogestational Antiandrogens1Endocrinology, 1974
- THE STIMULATION OF MALE DUCT DERIVATIVES IN FEMALE GUINEA-PIGS WITH AN ANTIANDROGEN, CYPROTERONE ACETATEReproduction, 1974
- Biological studies on an anti-androgen (SH 714)European Journal of Pharmacology, 1967
- ENDOCRINE CONTROL OF PROSTATIC CARCINOMAJAMA, 1950